NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.
Gedeon Richter's drug is the only licensed GnRH antagonist option and, unlike GnRH agonists like Takeda's Prostap ...
Endometriosis occurs when cells similar to those in the lining of the womb grow in other parts of the body, such as the ...
The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...
The NICE has approved the first daily oral treatment for endometriosis symptoms for use within the NHS in England.
A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected.